In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Dr. David Fairchild, CVS Health
The battle against tobacco and nicotine use continues.
Video Forum: Nourishing Change Conference
Conference to explore how health care is delivered.
Video Forum: Jody Hatcher, HDA
Healthcare Distribution Alliance chairman on what lies ahead.
Latest
RazorMetrics report finds nearly half of Americans say they've been prescribed a drug they can't afford
2025 State of Drug Access report from RazorMetrics reveals new insights into consumer feelings about pharmacy access.
CRN updates magnesium safety guidelines
The updated UL is part of CRN’s ongoing release of revised nutrient safety chapters from its Vitamin and Mineral Safety (4th edition).
GoodRx Tracker reveals inflation’s toll on prescriptions and consumer essentials
Prescription medications have seen the highest inflation compared to other medical goods, like nonprescription medications and medical equipment.
NACDS Foundation awards over $245,000 for scholarships and grants in 2025
The recipients were awarded at a special ceremony marking 30 years of NACDS Foundation scholarships, held during the 2025 NACDS Annual Meeting in Palm Beach, Florida.